KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Pacira BioSciences (PCRX) over the last 15 years, with Q3 2025 value amounting to $86.2 million.

  • Pacira BioSciences' Change in Acquisitions & Divestments rose 6222.89% to $86.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $273.6 million, marking a year-over-year increase of 6216.33%. This contributed to the annual value of $179.6 million for FY2024, which is 2425.3% down from last year.
  • Pacira BioSciences' Change in Acquisitions & Divestments amounted to $86.2 million in Q3 2025, which was up 6222.89% from $71.2 million recorded in Q2 2025.
  • Pacira BioSciences' Change in Acquisitions & Divestments' 5-year high stood at $598.1 million during Q4 2021, with a 5-year trough of $33.5 million in Q2 2023.
  • In the last 5 years, Pacira BioSciences' Change in Acquisitions & Divestments had a median value of $70.2 million in 2025 and averaged $108.3 million.
  • As far as peak fluctuations go, Pacira BioSciences' Change in Acquisitions & Divestments skyrocketed by 29066.64% in 2021, and later plummeted by 8579.89% in 2022.
  • Pacira BioSciences' Change in Acquisitions & Divestments (Quarter) stood at $598.1 million in 2021, then crashed by 85.8% to $84.9 million in 2022, then tumbled by 57.5% to $36.1 million in 2023, then surged by 30.05% to $46.9 million in 2024, then surged by 83.72% to $86.2 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $86.2 million for Q3 2025, versus $71.2 million for Q2 2025 and $69.2 million for Q1 2025.